healthcare research

In Collaboration with the National Institutes of Health, IBM Research Dives Deep into Biomarkers of Schizophrenia

In collaboration with researchers from Harvard Medical School, Mt. Sinai School of Medicine, Stanford University and the Northern California Institute for Research and Education, IBM Research is undertaking a new research initiative funded by the National Institute of Health.

Continue reading

AI Data Tracker Encourages Scientific Research into COVID-19 Non-Pharmaceutical Interventions

What impact do measures such as shelter-in-place, mask wearing, and social distancing have on the number of COVID-19 cases? How do the COVID-19 quarantine measures that have been implemented by North American countries compare to South American countries? These are just a few questions about the wide range of non-pharmaceutical interventions (NPIs) that have been applied by governments, globally.

Continue reading

IBM Research and the Broad Institute Seek to Unravel the True Risks of Genetic Diseases

In 2019, IBM and the Broad Institute of MIT and Harvard started a multi-year collaborative research program to develop powerful predictive models that can potentially enable clinicians to identify patients at serious risk for cardiovascular disease (1, 2). At the start of our collaboration, we proposed an approach to develop AI-based models that combine and […]

Continue reading

Helping Advance Huntington’s Disease Research by Using AI to Map the Human Brain

In a new study, IBM and CHDI researchers studied the relationship between the pace of subtle cognitive decline in patients before full-fledged symptoms and their brain activity, as shown by a functional MRI. The results demonstrate that measuring the potential progression of HD could eventually be done from a single brain scan, acquired in one visit.

Continue reading

AI Models Predict Breast Cancer with Radiologist-Level Accuracy

Our team of IBM researchers published research in Radiology around a new AI model that can predict the development of malignant breast cancer in patients within the year, at rates comparable to human radiologists.

Continue reading

IBM and Johns Hopkins University School of Medicine Discover Unique, Pathogenic Autoimmune Cells in Type 1 Diabetes

Researchers at JHU and IBM identify new cells involved in the autoimmune attack on insulin-producing cells in type 1 diabetes.

Continue reading

Continuous-Flow Reactor Could Potentially Help Speed Drug Discovery

New continuous-flow approach to chemical synthesis holds promise in accelerating therapeutic discovery for drug-resistant infectious diseases and cancer.

Continue reading

Research Using IBM Cloud and AI Sheds Light on Huntington’s Disease (HD)

New research combining the power of brain modeling, IBM’s AI, and the IBM Cloud sheds light on how brain cells interact in Huntington’s disease.

Continue reading

Deciphering Breast Cancer Heterogeneity Using Machine Learning

A comprehensive analysis of tumor ecosystems that represents an important step in research that may lead to precision medicine approaches to treat breast cancer.

Continue reading

Exploring the Expressive Range of Conversational Laughter with AI

IBM scientists use crowdsourcing and AI techniques to explore what different types of conversational laughter can tell us.

Continue reading

AI Holds Promise for Glaucoma, a Leading Global Cause of Blindness

IBM Research and New York University are using AI to analyze retina imaging data and help to assess the presence of glaucoma.

Continue reading

Could Mitochondria Numbers Be the Key to Solving Cancer Drug Resistance?

New research shows that the number of mitochondria in a cell is associated with drug resistance, which could have a far-reaching impact in cancer treatment.

Continue reading